Medication Fact Sheets
|
November 27, 2024

Rosuvastatin: Benefits, Side Effects, and Key Considerations for Patients and Healthcare Professionals

Medically Reviewed by
Updated On
December 2, 2024

Rosuvastatin, or Crestor, is a medication that lowers cholesterol. Rosuvastatin belongs to a class of drugs called HMG-CoA reductase inhibitors (statins).[20] Other medicines in this class include atorvastatin, pravastatin, and simvastatin. These drugs are used to treat high cholesterol and prevent heart disease, strokes, and heart attacks.[20]

[signup]

How Rosuvastatin Works

Rosuvastatin and other medications in the statin class work at the liver's level to decrease cholesterol production.  

Mechanism of Action

Statins selectively inhibit hydroxymethylglutaryl-CoA (HMG-CoA) reductase, which converts HMG-CoA to mevalonate during the synthesis of cholesterol.[24] They also inhibit the synthesis of other compounds in the cellular signaling proteins. They also have anti-inflammatory, antioxidant, antiproliferative, and immune system effects. They can stabilize cholesterol plaques that can form in arteries and keep platelets from sticking together and blocking arteries.[24]

By decreasing cholesterol synthesis, rosuvastatin can decrease LDL cholesterol levels. In addition, it also increases HDL cholesterol levels.[17] Rosuvastatin also lowers triglyceride levels by improving other cholesterol markers such as VLDL and apoC-III.[13]

Studies have shown that rosuvastatin can delay the progression of atherosclerosis and may also help prevent cardiovascular disease, even in people with low LDL levels.[5,6] A 2010 study published in the European Heart Journal showed a 54% reduction in heart attacks and a 48% reduction in stroke.[6]

Dosage and Administration

Rosuvastatin is a tablet that is taken orally (by mouth). Dosing ranges from 5mg to 40mg daily. 

  • In most people, dosing is usually started at 10 or 20 mg daily.[19] People with homozygous familial hypercholesterolemia are generally started on 20mg daily. People with very high cholesterol or a high risk for cardiovascular disease may be started on 40mg daily.[9]
  • Rosuvastatin is approved by the Food and Drug Administration (FDA) to treat children aged 7 to 17 with homozygous familial hypercholesterolemia and children aged 8 to 17 with heterozygous familial hypercholesterolemia.[21] The maximum dose in children is 20mg daily.[9]
  • People who have active liver disease should not use statin medications. People who have metabolic dysfunction associated with steatotic liver disease (MASLD) can be treated with statins, as can people with chronic liver disease who also have atherosclerotic cardiovascular disease.[24]
  • People with severe kidney impairment who are not on dialysis should be started on 5mg and should not be put on more than 10mg. It is reasonable to consider a lower starting dose (5mg) in the Asian population.[19

Effectiveness and Benefits

Multiple studies have confirmed the benefits of statin medications in both primary and secondary prevention of cardiovascular disease in people with high LDL or low HDL levels. Rosuvastatin appears to have the best results for lowering total cholesterol, LDL cholesterol, non-HDL cholesterol, and increasing HDL cholesterol.[11,12] 

Studies have also shown that, in high doses, statin medications can slow or even stop the progression of atherosclerosis

  • The JUPITER study also demonstrated a decreased risk of developing deep venous thrombosis or pulmonary embolism by 43%.[13] The JUPITER study was also the first study of statin medications that showed benefits in several subgroups, including women, Blacks, Hispanics, and the elderly.[13]

Rosuvastatin Side Effects and Safety

Some of the common (occurring in at least 1% of people) side effects of rosuvastatin include [9, 14,16,17]:

  • Nausea (2%)
  • Headaches (4%)
  • Abdominal pain (3%)
  • Fatigue (2%)
  • Dizziness (1-2%) 
  • Constipation
  • Proteinuria (3%)
  • Muscle aches (3-6%)

Muscle aches can be benign but may also be a sign of more severe side effects. One of the mechanisms believed to cause muscle pain is calcium leaking from within cells. The calcium leak may damage muscle cells. The leaking is spontaneous and irregular, and researchers believe that most people’s muscle cells can tolerate it without damage.[7]

Serious Side Effects

Rosuvastatin can also cause potentially serious side effects. While these side effects are rare, they can be severe and even life-threatening. 

These include [27]:

Serious side effects may be more common in people who are over age 65 or who have underlying kidney or liver disease.[18]

Managing and Minimizing Side Effects

Monitoring for and managing potential side effects often involves laboratory (blood) testing. For example: 

  • Liver function tests (LFT) help assess for liver damage. LFT elevation occurs in 1-3% of patients using rosuvastatin.[12] Usually, the elevation is mild and doesn’t require any treatment or dose adjustment. 
  • Liver function should be tested before rosuvastatin therapy is started and should be repeated as clinically indicated.[12] If ALT levels rise above 10-fold in someone without symptoms or 5-fold in someone with symptoms, the medication should be stopped. Symptoms usually resolve in 1-2 months.[12]

You can minimize side effects of rosuvastin by: 

  • Eating meals that aren’t rich or spicy may help with nausea. 
  • Staying well hydrated can help reduce kidney side effects and headaches. 
  • Eating and drinking slowly and resting if you feel tired or dizzy may help offset some side effects. 
  • Increasing fiber and minimizing alcohol use is also recommended.[27]

Seek urgent medical evaluation for any of the following: [27]

  • Severe muscle pain, tenderness, or weakness
  • Yellowing of skin or eyes
  • Severe abdominal pain
  • Double vision, drooping eyelids, weakness after activity
  • Pink-red rash on palms of hands or soles of feet
  • Cough with shortness of breath and weight loss
  • Difficulty swallowing

Special Considerations and Contraindications

Patients with certain conditions should avoid rosuvastatin. For example: 

  • Liver disease: Rosuvastatin is not recommended in people with active liver disease. It may be used in people with chronic liver disease with regular monitoring. Statin therapy, including rosuvastatin, shouldn’t be used in people with a severe allergy to the medications.[24]
  • Pregnancy: All statin medications are currently contraindicated during pregnancy and while breastfeeding. In scarce circumstances, the healthcare team may recommend continuing statin medications during pregnancy, but generally, treatment of hyperlipidemia is not necessary during pregnancy. [14, 16

Interactions with Other Medications

Rosuvastatin should be used cautiously and under the care of a healthcare provider by patients who are taking medications such as: [7,10]

Monitoring and Follow-Up

Routine monitoring of liver function and lipid profiles can help ensure that treatment is effective and not causing harm to organs such as the liver. Current guidelines recommend checking: 

  • LFTs about 12 weeks after starting therapy and then at least annually after. 
  • Lipids at 6-8 weeks after starting therapy and then every 4-6 months.  
  • Creatinine kinase (CK) at baseline and if there are any symptoms of muscle pain.[8]

Rosuvastatin in Special Populations

Some populations require additional consideration for the initiation and monitoring of rosuvastatin.

Older Adults

The ACC/AHA 2018 guidelines recommend considering initiating statin therapy in adults over 75 years if they have diabetes for primary prevention of atherosclerotic cardiovascular disease. They also recommend continuing previously initiated statins in people over 75 because they are at the greatest risk for cardiovascular disease.  Generally, the recommendation is to start with a lower dosage, less aggressive treatment.[16]

Patients with Chronic Conditions

  • People with advanced kidney disease should be started on a lower dose of rosuvastatin and titrating with caution. 
  • Statins should be avoided in people with active liver disease. People with chronic liver disease can use statins, but they need to be monitored more closely.[25]

Pregnancy and Lactation

Rosuvastatin and other members of the statin class are contraindicated in pregnancy due to a concern about the medications interfering with the developing embryo.[10

  • In 2021, the FDA removed the pregnancy category X label from the statin medications due to growing data that statins may be safe during pregnancy and may have some benefit for certain people with high-risk conditions. However, there is still a recommendation to discontinue statin treatment for most pregnant patients.[10]

Patient Education and Support

There is a lot of potentially confusing information out there on statin medications. Compliance with medications is vital to getting the best outcomes. Patient education and support play a vital role in ensuring compliance with medication.

Understanding the Risks and Benefits

One way to help patients understand the impact of statin medications on their health is to use a risk calculator to better demonstrate risks specific to their health status. 

  • The ASCVD risk calculator is one such tool. This tool estimates risk based on age, sex, race, blood pressure, cholesterol levels, medications, and risk factors such as history of diabetes and smoking status.[27]

Addressing Patient Concerns

Statins are used as long-term therapies. Patients may often have concerns about any medication that is used long-term. Multiple studies have shown that the benefits of statin medications outweigh the risks in most patients. 

Preparing patients for the possible side effects of medications and discussing strategies for managing the side effects, as well as the warning signs for serious complications, can help patients feel empowered if they encounter any issues or side effects.

Lifestyle and Medication Adherence

Cholesterol medications work best in combination with diet and exercise. A heart-healthy diet limits your saturated and trans fats while using healthier oils. The American Heart Association also recommends at least 150 minutes of moderate-intensity aerobic exercise to lower blood pressure and cholesterol.[15]

[signup]

Key Takeaways

Rosuvastatin is an effective medication for lowering cholesterol and decreasing the risk of cardiovascular disease.

  • Doses start at 5mg but may be higher if high-risk.
  • Regular monitoring of liver function and cholesterol helps to catch side effects early and to ensure effectiveness.
  • Statins are contraindicated in pregnancy and breastfeeding, but the data is changing.
  • Statins are long-term therapy that works best with diet and exercise
  • Statins work best with lifestyle modifications
The information in this article is designed for educational purposes only and is not intended to be a substitute for informed medical advice or care. This information should not be used to diagnose or treat any health problems or illnesses without consulting a doctor. Consult with a health care practitioner before relying on any information in this article or on this website.

Learn more

No items found.

Lab Tests in This Article

No lab tests!
  1. ASCVD Risk Estimator +. (n.d.). https://tools.acc.org/ascvd-risk-estimator-plus/#!/calculate/estimate/
  2. Dosage and Administration | CRESTOR® (rosuvastatin) | For HCPs. (n.d.). https://www.crestor.com/hcp/about-crestor/dosing-administration.html
  3. Familial Hypercholesterolemia and Pregnancy - American College of Cardiology. (2018, May 10). American College of Cardiology. https://www.acc.org/Latest-in-Cardiology/Articles/2018/05/10/13/51/Familial-Hypercholesterolemia-and-Pregnancy
  4. Glynn, R. J., Danielson, E., Fonseca, F. A., Genest, J., Gotto, A. M., Kastelein, J. J., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., Nordestgaard, B. G., Shepherd, J., Willerson, J. T., & Ridker, P. M. (2009). A randomized trial of rosuvastatin in the prevention of venous thromboembolism. New England Journal of Medicine, 360(18), 1851–1861. https://doi.org/10.1056/nejmoa0900241
  5. Keating, G. M., & Robinson, D. M. (2008). Rosuvastatin. American Journal of Cardiovascular Drugs, 8(2), 127–146. https://doi.org/10.1007/bf03256589
  6. Koenig, W., & Ridker, P. M. (2010). Rosuvastatin for primary prevention in patients with European systematic coronary risk evaluation risk ≥5% or Framingham risk >20%: post hoc analyses of the JUPITER trial requested by European health authorities. European Heart Journal, 32(1), 75–83. https://doi.org/10.1093/eurheartj/ehq370
  7. Lotteau, S., Ivarsson, N., Yang, Z., Restagno, D., Colyer, J., Hopkins, P., Weightman, A., Himori, K., Yamada, T., Bruton, J., Steele, D., Westerblad, H., & Calaghan, S. (2019). A mechanism for Statin-Induced susceptibility to myopathy. JACC Basic to Translational Science, 4(4), 509–523. https://doi.org/10.1016/j.jacbts.2019.03.012
  8. Lowe, R. N., Marrs, J. C., & Saseen, J. J. (2013). Patterns of serum laboratory monitoring for safety and efficacy in patients on chronic statin therapy. Therapeutic Advances in Drug Safety, 4(1), 9–17. https://doi.org/10.1177/2042098612474293
  9. Malik, S., & Cohen, P. R. (2022). Rosuvastatin-Induced dizziness and pruritus: A case report and summary of Statin-Associated dizziness and pruritus. Cureus. https://doi.org/10.7759/cureus.29014
  10. Mauricio, R., & Khera, A. (2022). Statin use in pregnancy: Is it time for a paradigm shift? Circulation, 145(7), 496–498. https://doi.org/10.1161/circulationaha.121.058983
  11. Michos, E., Narla, V., Blaha, M., & Blumenthal, R. (2009). The JUPITER and AURORA clinical trials for rosuvastatin in special primary prevention populations: perspectives, outcomes, and consequences. Vascular Health and Risk Management, 1033. https://doi.org/10.2147/vhrm.s6412
  12. National Institute of Diabetes and Digestive and Kidney Diseases. (2021, December 1). Rosuvastatin. LiverTox - NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK548620/
  13. Ooi, E. M., Watts, G. F., Chan, D. C., Chen, M. M., Nestel, P. J., Sviridov, D., & Barrett, P. H. R. (2008). Dose-Dependent effect of rosuvastatin on VLDL–Apolipoprotein C-III kinetics in the metabolic syndrome. Diabetes Care, 31(8), 1656–1661. https://doi.org/10.2337/dc08-0358
  14. Pregnancy, statins, and high cholesterol: What women need to know | Heart | Women’s Health | Your Pregnancy Matters | UT Southwestern Medical Center. (n.d.). https://utswmed.org/medblog/statins-pregnancy-familial-hypocholesteremia/
  15. Prevention and treatment of high cholesterol (Hyperlipidemia). (2024, October 16). www.heart.org. https://www.heart.org/en/health-topics/cholesterol/prevention-and-treatment-of-high-cholesterol-hyperlipidemia
  16. Research, C. F. D. E. A. (2021, August 30). FDA requests removal of strongest warning against using cholesterol-lowering statins during pregnancy; still advises most pregnant patients should stop taking statins. U.S. Food And Drug Administration. https://www.fda.gov/drugs/drug-safety-and-availability/fda-requests-removal-strongest-warning-against-using-cholesterol-lowering-statins-during-pregnancy
  17. Rosenson, R. S., Otvos, J. D., & Hsia, J. (2009). Effects of rosuvastatin and atorvastatin on LDL and HDL particle concentrations in patients with metabolic syndrome. Diabetes Care, 32(6), 1087–1091. https://doi.org/10.2337/dc08-1681
  18. Rosuvastatin (oral route). (2024, October 1). Mayo Clinic. https://www.mayoclinic.org/drugs-supplements/rosuvastatin-oral-route/description/drg-20065889
  19. Rosuvastatin. (n.d.). https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=7f6d9c9d-9065-695b-e053-2a91aa0af650
  20. Rosuvastatin: MedlinePlus drug information. (n.d.). https://medlineplus.gov/druginfo/meds/a603033.html
  21. Rosuvastatin: uses, dosage, side effects, warnings. (n.d.). Drugs.com. https://www.drugs.com/rosuvastatin.html
  22. Safety and Side Effects | CRESTOR® (rosuvastatin) | For HCPs. (n.d.). https://www.crestor.com/hcp/side-effects.html
  23. Schuster, H., Barter, P. J., Stender, S., Cheung, R. C., Bonnet, J., Morrell, J. M., Watkins, C., Kallend, D., & Raza, A. (2004). Effects of switching statins on achievement of lipid goals: measuring effective reductions in cholesterol using rosuvastatin therapy (MERCURY I) study. American Heart Journal, 147(4), 705–712. https://doi.org/10.1016/j.ahj.2003.10.004
  24. Sizar, O., Khare, S., Patel, P., & Talati, R. (2024, February 29). Statin medications. StatPearls - NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK430940/
  25. Statin therapy in older adults for primary prevention of atherosclerotic cardiovascular disease: The Balancing Act - American College of Cardiology. (2020, October 1). American College of Cardiology. https://www.acc.org/Latest-in-Cardiology/Articles/2020/10/01/11/39/Statin-Therapy-in-Older-Adults-for-Primary-Prevention-of-Atherosclerotic-CV-Disease
  26. Website, N. (2022, March 22). How and when to take rosuvastatin. nhs.uk. https://www.nhs.uk/medicines/rosuvastatin/how-and-when-to-take-rosuvastatin/
  27. Website, N. (2024, October 7). Side effects of rosuvastatin. nhs.uk. https://www.nhs.uk/medicines/rosuvastatin/side-effects-of-rosuvastatin/
  28. Zipes, D. P., Zvaifler, N. J., Glassock, R. J., Gilman, S., Muñoz, A., Gogolak, V., Gordis, L., Dedon, P. C., Guengerich, F. P., Wasserman, S. I., Witztum, J. L., & Wogan, G. N. (2006, June 14). Rosuvastatin: An Independent Analysis of Risks and benefits. https://pmc.ncbi.nlm.nih.gov/articles/PMC1785157/
Order from 30+ labs in 20 seconds (DUTCH, Mosaic, Genova & More!)
We make ordering quick and painless — and best of all, it's free for practitioners.

Latest Articles

View more on Medication Fact Sheets
Subscribe to the Magazine for free
Subscribe for free to keep reading! If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Subscribe to the Magazine for free to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Trusted Source
Rupa Health
Medical Education Platform
Visit Source
Visit Source
American Cancer Society
Foundation for Cancer Research
Visit Source
Visit Source
National Library of Medicine
Government Authority
Visit Source
Visit Source
Journal of The American College of Radiology
Peer Reviewed Journal
Visit Source
Visit Source
National Cancer Institute
Government Authority
Visit Source
Visit Source
World Health Organization (WHO)
Government Authority
Visit Source
Visit Source
The Journal of Pediatrics
Peer Reviewed Journal
Visit Source
Visit Source
CDC
Government Authority
Visit Source
Visit Source
Office of Dietary Supplements
Government Authority
Visit Source
Visit Source
National Heart Lung and Blood Institute
Government Authority
Visit Source
Visit Source
National Institutes of Health
Government Authority
Visit Source
Visit Source
Clinical Infectious Diseases
Peer Reviewed Journal
Visit Source
Visit Source
Brain
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Rheumatology
Peer Reviewed Journal
Visit Source
Visit Source
Journal of the National Cancer Institute (JNCI)
Peer Reviewed Journal
Visit Source
Visit Source
Journal of Cardiovascular Magnetic Resonance
Peer Reviewed Journal
Visit Source
Visit Source
Hepatology
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Clinical Nutrition
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Bone and Joint Surgery
Peer Reviewed Journal
Visit Source
Visit Source
Kidney International
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Allergy and Clinical Immunology
Peer Reviewed Journal
Visit Source
Visit Source
Annals of Surgery
Peer Reviewed Journal
Visit Source
Visit Source
Chest
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Neurology, Neurosurgery & Psychiatry
Peer Reviewed Journal
Visit Source
Visit Source
Blood
Peer Reviewed Journal
Visit Source
Visit Source
Gastroenterology
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Respiratory and Critical Care Medicine
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Psychiatry
Peer Reviewed Journal
Visit Source
Visit Source
Diabetes Care
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of the American College of Cardiology (JACC)
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Clinical Oncology (JCO)
Peer Reviewed Journal
Visit Source
Visit Source
Journal of Clinical Investigation (JCI)
Peer Reviewed Journal
Visit Source
Visit Source
Circulation
Peer Reviewed Journal
Visit Source
Visit Source
JAMA Internal Medicine
Peer Reviewed Journal
Visit Source
Visit Source
PLOS Medicine
Peer Reviewed Journal
Visit Source
Visit Source
Annals of Internal Medicine
Peer Reviewed Journal
Visit Source
Visit Source
Nature Medicine
Peer Reviewed Journal
Visit Source
Visit Source
The BMJ (British Medical Journal)
Peer Reviewed Journal
Visit Source
Visit Source
The Lancet
Peer Reviewed Journal
Visit Source
Visit Source
Journal of the American Medical Association (JAMA)
Peer Reviewed Journal
Visit Source
Visit Source
Pubmed
Comprehensive biomedical database
Visit Source
Visit Source
Harvard
Educational/Medical Institution
Visit Source
Visit Source
Cleveland Clinic
Educational/Medical Institution
Visit Source
Visit Source
Mayo Clinic
Educational/Medical Institution
Visit Source
Visit Source
The New England Journal of Medicine (NEJM)
Peer Reviewed Journal
Visit Source
Visit Source
Johns Hopkins
Educational/Medical Institution
Visit Source
Visit Source

Hey Practitioners! On December 11th, join Dr. Terry Wahls in a free live class where she'll share her groundbreaking methods for managing MS and autoimmune patients. This live session will address your most pressing questions and will take a closer look at treatment options beyond the conventional standards of care. Register here.

Register Here